We are developing increasingly effective therapies for patients with chronic hepatitis C, yet many physicians who treat a high volume of these patients are struggling to maintain economically viable strategies for providing care. Is treatment of hepatitis C becoming a money-losing proposition? Can a few simple adjustments revitalize your clinic's financial outlook? Dr. Imtiaz Alam, founding medical director of the Austin Hepatitis Center in Austin, Tex., joins host Dr. David Rubin.